Alteration of the cytoplasmic/nuclear expression pattern of Galectin-3 correlates with prostate carcinoma progression

International Journal of Cancer

Volumn 89, Issue 4, 2000, Pages 361-367

  Van Den Brûle, Frédéric A ^a,c   Waltregny, David ^a   Liu, Fu Tong ^b   Castronovo, Vincent ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c Pathology B23   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 3; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CARCINOMA IN SITU; CELL NUCLEUS; CELLULAR DISTRIBUTION; CYTOPLASM; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA;

EID: 0343962593     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000720)89:4<361::aid-ijc8>3.3.co;2-l     Document Type: Article

References (55)

1. AKAHANI, S., NANGIA-MAKKER, P., INOHARA, H., KIM, H.R. and RAZ, A., Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res., 57, 5272-5276 (1997).
2. ARENAS, M.I., ROMO, E., DE GASPAR, I., DE BETHENCOURT, F.R., SANCHEZ-CHAPADO, M., FRAILE, B. and PANIAGUA, R., A lectin histochemistry comparative study in human normal prostate, benign prostatic hyperplasia. and PROSTATIC CARCINOMA. Glycoconj. J., 16, 375-382 (1999).
3. BARONDES, S.H. and 20 OTHERS, Galectins: a family of animal β-galactoside-binding lectins. Cell. 76, 597-598 (1994a).
4. BARONDES, S.H., COOPER, D.N.W., GITT, M.A. and LEFFLER, H., Galectins: structure and function of a large family of animal lectins. J. biol. Chem., 269, 20807-20810 (1994b).
5. BOAG, A.H. and YOUNG, I.D., Increased expression of the 72-kd type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization. Amer. J. Pathol., 144, 585-591 (1994).
6. BOSTWICK, D.G. and SAKR, W., Prostatic intraepithelial neoplasia. In C.S. Foster and D.G. Bostwick (eds.), Pathology of the prostate, major problems in pathology, Vol. 34, pp. 95-113, W.B. Saunders, Philadelphia (1998).
7. BRESALIER, R.S., BYRD, J.C., WANG, L. and RAZ, A., Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3. Cancer Res., 56, 4354-4357 (1996).
8. CASTRONOVO, V., CAMPO, E., VAN DEN BRULE, F.A., CLAYSMITH, A.P., CIOCE, V., LIU, F.T., FERNANDEZ, P.L. and SOBEL, M.E., Inverse modulation of steady-state messenger RNA levels of two non-integrin laminin-binding proteins in human colon carcinoma. J. nat. Cancer Inst., 84, 1161-1169 (1992).
9. CASTRONOVO, V., VAN DEN BRULE, F.A., JACKERS, P., CLAUSSE, N., LIU, F.T., GILLET, C. and SOBEL, M.E., Decreased expression of galectin-3 is associated with progression of human breast cancer. J. Pathol., 179, 43-48 (1996).
10. COLOMBEL, M., SYMMANS, F., GIL, S., O'TOOLE, K.M., CHOPIN, D., BENSON, M., OLSSON, C.A., KORSMEYER, S. and BUTTYAN, R., Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Amer. J. Pathol., 143, 390-400 (1993).
11. COWLES, E.A., AGRWAL, N., ANDERSON, R.L. and WANG, J.L., Carbohydrate-binding protein 35. Isoelectric points of the polypeptide and a phosphorylated derivative. J. biol. Chem., 265, 17706-17712 (1990).
12. COX, D.R., Regression models and life tables. J. R. stat. Soc., 34, 187 (1972).
13. DAGHER, S.F., WANG, J.L. and PATTERSON, R.J., Identification of galectin-3 as a factor in pre-mRNA splicing. Proc. nat. Acad. Sci. (Wash.), 92, 1213-1217 (1995).
14. FRIGERI, L.G. and LIU, F.-T., Surface expression of a functional IgE binding protein, an endogenous lectin, on mast cells and macrophages. J. Immunol. 148, 861-867 (1992).
15. GLEASON, D.F. and MELLINGER, G.T., Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol., 111, 58-64 (1974).
16. GRAHAM, C. and KARNOVSKY, M.J., The early stages of absorbtion of horseradish peroxidase in the proximal tubules of mouse kidneys: ultrastructural cytochemistry by a new technique. J. Histochem. Cytochem., 14, 291 (1966).
17. GRITZMACHER, C.A., ROBERTSON, M.W. and LIU, F.T., IgE-binding protein. Subcellular location and gene expression in many murine tissues and cells. J. Immunol., 141, 2801-2806 (1988).
18. HSU, D.K., ZUBERI, R.I. and LIU, F.-T., Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin. J. biol. Chem., 267, 14167-14174 (1992).
19. HUFLEJT, M.E., TURCK, C.W., LINSTEDT, R., BARONDES, S.H. and LEFFLER, H., L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I. J. biol. Chem., 268, 26712-26718 (1993).
20. INOHARA, H., AKAHANI, S., KOTHS, K. and RAZ, A., Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res., 56, 4530-4534 (1996).
21. INOHARA, H. and RAZ, A., Identification of human melanoma cellular and secreted ligands for galectin-3. Biochem. biophys. Res. Commun., 201, 1366-1375 (1994).
22. INOHARA, H. and RAZ, A., Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res., 55, 3267-3271 (1995).
23. IRIMURA, T., MATSUSHITA, Y., SUTTON, R.C., CARRALERO, D., OHANNESIAN, D.W., CLEARY, K.R., OTA, D.M., NICOLSON, G.L. and LOTAN, R., Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Res., 51, 387-393 (1991).
24. JIA, S. and WANG, J.L., Carbohydrate binding protein 35. Complementary DNA sequence reveals homology with proteins of the heterogeneous nuclear RNP. J. biol. Chem., 263, 6009-6011 (1988).
25. KAPLAN, E.L. and MEIER, P., Nonparametric estimation from incomplete observations. J. amer. stat. Assoc., 53, 457-481 (1958).
26. KUKLINSKI, S. and PROBSTMEIER, R., Homophilic binding properties of galectin-3: involvement of the carbohydrate recognition domain. J. Neurochem., 70, 814-823 (1998).
27. KUWABARA, I. and LIU, F.T., Galectin-3 promotes adhesion of human neutrophils to laminin. J. Immunol., 156, 3939-3944 (1996).
28. LAING, J.G. and WANG, J.L., Identification of carbohydrate binding protein 35 in heterologous nuclear ribonucleoprotein complex. Biochemistry, 27, 5329-5334 (1998).
29. LEHR, J.E. and PIENTA, K.J., Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J. nat. Cancer Inst., 90, 118-123 (1998).
30. LE MARER, N. and HUGHES, R.C., Effects of the carbohydrate-binding protein galectin-3 on the invasiveness of human breast carcinoma cells. J. cell. Physiol., 168, 51-58 (1996).
31. LOTZ, M.M., ANDREWS, C.W. JR., KORZELIUS, C.A., LEE, E.C., STEELE, G.D. JR., CLARKE, A. and MERCURIO, A.M., Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc. nat. Acad. Sci. (Wash.), 90, 3466-3470 (1993).
32. MASSA, S.M., COOPER, D.N.W., LEFFLER, H. and BARONDES, S.H., L-29, an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity. Biochemistry, 32, 260-267 (1993).
33. MOSTOFI, F.K., DAVIS, C.J.J. and SESTERHENN, I.A., Histopathology of prostate cancer. In H. Lepor and R. Lawson (eds.), Prostate diseases, pp. 229-256, W.B. Saunders. Philadelphia (1993).
34. MOUTSATSOS, I.K., WADE, M., SCHINDLER, M. and WANG, J.L., Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts. Proc. nat. Acad. Sci. (Wash.), 4, 6452-6456 (1987).
35. NAGLE, R.B., BRAWER, M.K., KITTELSON, J. and CLARK, V., Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma. Amer. J. Pathol., 138, 119-128 (1991).
36. OCHIENG, J., GEROLD, M. and RAZ, A., Dichotomy in the laminin-binding properties of soluble and membrane-hound human galactoside-binding protein. Biochem. biophys. Res. Commun., 186, 1674-1680(1992).
37. ODA, Y., LEFFLER, H., SAKAKURA, Y., KASAI, K. and BARONDES, S.H., Human breast carcinoma cDNA encoding a galactoside-binding lectin homologous to mouse Mac-2 antigen. Gene, 99, 279-283 (1991).
38. OHANNESIAN, D.W., LOTAN, D., THOMAS, P., JESSUP, J.M., FUKUDA, M., GABIUS, H.J. and LOTAN, R., Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res., 55, 2191-2199 (1995).
39. PERLMAN, E.J. and EPSTEIN, J.I., Blood group antigen expression in dysplasia and adenocarcinoma of the prostate. Amer. J. surg. Pathol., 14, 810-818 (1990).
40. PIENTA, K.J., NAIK, H., AKHTAR, A., YAMAZAKI, K., REPLOGLE, T.S., LEHR, J., DONAT, T.L., TAIT, L., HOGAN, V. and RAZ, A., Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J. nat. Cancer Inst., 87, 348-353 (1995).
41. PLATT, D. and RAZ, A., Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin. J. nat. Cancer Inst., 84, 438-142 (1992).
42. RAZ, A., PAZERINI, G. and CARMI, P., Identification of the metastasis-associated, galactoside-binding lectin as a chimeric gene product with homology to an IgE-binding protein. Cancer Res., 49, 3489-3493 (1989).
43. SANJUAN, X., FERNANDEZ, P.L., CASTELLS, A., CASTRONOVO, V., VAN DEN BRÛLE, F.A., LIU, F.-T., CARDESA, A. and CAMPO, E., Differential expression of galectin-3 and galectin-1 in colorectal cancer progression. Gastroenterology, 113, 1906-1915 (1997).
44. SATO, S. and HUGHES, R.C., Binding specificity of a baby hamster kidney lectin for H type I and II chains, polylactosamine glycans, and appropriately glycosylated forms of laminin and fibronectin. J. biol. Chem., 267, 6985-6990 (1992).
45. SATO, S. and HUGHES, R.C., Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. J. biol. Chem., 269, 4424-4430 (1994).
46. SCHOEPPNER, H.L., RAZ, A., HO, S.B. and BRESALIER, R.S., Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer. 75, 2818-2826 (1995).
47. SCHRODER, F.H., HERMANEK, P., DENIS, L., FAIR, W.R., GOSPODAROWICZ, M.K. and PAVONE-MACALUSO, M., The TNM classification of prostate cancer. Prostate Suppl., 4, 129-138 (1992).
48. VAN DEN BRÛLE, F.A., BUICU, C., BERCHUCK, A., BAST, R.C., DEPREZ, E., LIU, F.-T., COOPER, D.N.W., PIETERS, C., SOBEL, M.E. and CASTRONOVO, V., Expression of the 67 kD laminin receptor, galectin-1 and galectin-3 in advanced uterine carcinoma. Hum. Pathol., 27, 1185-1191 (1996).
49. VAN DEN BRÛLE, F.A., BUICU, C., SOBEL, M.E., LIU, F.T. and CASTRONOVO, V., Galectin-3, a laminin binding protein, fails to modulate adhesion of human melanoma cells to laminin. Neoplasma, 42, 215-219 (1995).
50. VAN DEN BRÛLE, F.A. and CASTRONOVO, V., Laminin-binding lectins during cancer invasion and metastasis. In M. Caron and A.-P. Sève (eds.), Lectins and pathology, pp. 79-121, Harwood Academic Publishers (1999).
51. WALTREGNY, D., BELLAHCENE, A., VAN RIET, I., FISHER, L.W., YOUNG, M., FERNANDEZ, P., DEWE, W., DE LEVAL, J. and CASTRONOVO, V., Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J. nat. Cancer Inst., 90, 1000-1008 (1998).
52. WANG, L., INOHARA, H., PIENTA, K.J. and RAZ, A., Galectin-3 is a nuclear matrix protein which binds RNA. Biochem. biophys. Res. Commun., 217, 292-303 (1995).
53. WARFIELD, P.R., NANGIA-MAKKER, P., RAZ, A. and OCHIENG, J., Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3. Invasion Metastasis, 17, 101-112 (1997).
54. YANG, R.Y., HILL, P.N., HSU, D.K. and LIU, F.T., Role of the carboxyl-terminal lectin domain in self-association of galectin-3. Biochemistry, 37, 4086-4092 (1998).
55. YANG, R.Y., HSU, D.K. and LIU, F.T., Expression of galectin-3 modulates T-cell growth and apoptosis. Proc. nat. Acad. Sci. (Wash.), 93, 6737-6742 (1996).